|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,426.70 INR | -0.36% |
|
-3.24% | +15.23% |
| 05-25 | Jefferies Adjusts Torrent Pharmaceuticals' Price Target to INR5,350 From INR4,690, Keeps at Buy | MT |
| 05-22 | Torrent Pharmaceuticals Limited, Q4 2026 Earnings Call, May 22, 2026 |
| Market Cap | 1,498B 15.88B 13.84B 12.82B 12B 22.51B 22.65B 152B 58.95B 737B 59.6B 58.32B 2,561B | P/E 2027 * |
63.9x | P/E 2028 * | 47x |
|---|---|---|---|---|---|
| Enterprise Value | 1,612B 17.08B 14.89B 13.79B 12.91B 24.22B 24.36B 164B 63.41B 793B 64.11B 62.74B 2,754B | EV / Sales 2027 * |
8.5x | EV / Sales 2028 * | 7.43x |
| Free-Float |
28.81% | Yield 2027 * |
0.73% | Yield 2028 * | 0.82% |
Last Transcript: Torrent Pharmaceuticals Limited
| 1 day | -0.36% | ||
| 1 week | -3.24% | ||
| Current month | +0.74% | ||
| 1 month | -0.68% | ||
| 3 months | +5.17% | ||
| 6 months | +16.48% | ||
| Current year | +15.23% |
| 1 week | 4,415.8 |  | 4,600.1 |
| 1 month | 4,242 | | 4,714.5 |
| Current year | 3,724.1 | | 4,714.5 |
| 1 year | 3,139.5 | | 4,714.5 |
| 3 years | 1,771.35 | | 4,714.5 |
| 5 years | 1,242.5 | | 4,714.5 |
| 10 years | 571.75 | | 4,714.5 |
| Manager | Title | Age | Since |
|---|---|---|---|
Aman Samir Mehta
CEO | Chief Executive Officer | 34 | 2025-07-31 |
Sudhir Menon
DFI | Director of Finance/CFO | - | 2018-08-31 |
Geena Malhotra
CTO | Chief Tech/Sci/R&D Officer | - | 2026-01-31 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 62 | 2014-07-29 | |
| Director/Board Member | 46 | 2018-02-07 | |
Nayantara Bali
BRD | Director/Board Member | 59 | 2019-03-06 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 24-11-28 | Buy | Chief Operating Officer | 930,144 | 0.2748% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -0.36% | -3.24% | +39.73% | +138.26% | 15.88B | |
| -1.21% | -3.04% | +39.94% | +145.38% | 980B | |
| -2.48% | -5.18% | +51.52% | +39.07% | 550B | |
| -2.14% | -4.94% | +16.71% | +56.15% | 382B | |
| +0.25% | -3.09% | +23.00% | +15.81% | 316B | |
| +0.61% | -1.69% | +25.42% | +13.64% | 272B | |
| +0.22% | -3.10% | +24.25% | +30.21% | 268B | |
| +4.59% | +1.98% | -40.02% | -45.89% | 199B | |
| -1.19% | -4.95% | +16.56% | +47.00% | 182B | |
| -1.35% | -1.46% | +14.59% | +56.94% | 154B | |
| Average | -0.31% | -3.04% | +21.17% | +49.66% | 331.82B | |
| Weighted average by Cap. | -0.78% | -3.67% | +27.86% | +64.05% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 190B 2.01B 1.75B 1.62B 1.52B 2.85B 2.87B 19.25B 7.46B 93.31B 7.54B 7.38B 324B | 213B 2.26B 1.97B 1.82B 1.7B 3.2B 3.22B 21.6B 8.37B 105B 8.47B 8.28B 364B |
| Net income | 24.75B 262M 229M 212M 198M 372M 374M 2.51B 974M 12.18B 985M 963M 42.3B | 33.95B 360M 314M 291M 272M 510M 513M 3.45B 1.34B 16.71B 1.35B 1.32B 58.02B |
| Net Debt | 113B 1.2B 1.05B 971M 909M 1.7B 1.72B 11.52B 4.46B 55.85B 4.51B 4.42B 194B | 82.04B 869M 758M 702M 657M 1.23B 1.24B 8.33B 3.23B 40.38B 3.26B 3.19B 140B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-06-19 | 4,426.70 ₹ | -0.36% | 17,693 |
| 26-06-18 | 4,442.85 ₹ | -0.12% | 4,085 |
| 26-06-17 | 4,448.40 ₹ | -0.36% | 19,765 |
| 26-06-16 | 4,464.50 ₹ | -0.99% | 5,798 |
| 26-06-15 | 4,508.95 ₹ | -1.44% | 10,879 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TORNTPHARM Stock
Select your edition
All financial news and data tailored to specific country editions
